Last updated: February 20, 2026
What Is the Scope of Patent DK1973545?
Patent DK1973545 was filed in Denmark and covers a pharmaceutical invention. Its scope concentrates on a novel compound, formulation, or method, as detailed in the claims section. The patent aims to protect both the compound itself and its therapeutic applications.
The patent encompasses:
- Chemical entity or formulation: Specific molecular structures or compositions designed for therapeutic use.
- Method of use: Novel methods for treating particular diseases or conditions.
- Production process: Specific synthesis or manufacturing techniques.
The precise boundaries are defined by the claims, which establish what is and isn't protected. The patent's claims include independent claims that delineate the core invention and dependent claims that specify particular embodiments or additional features.
What Are the Key Claims?
Based on public records, DK1973545 contains:
- An independent claim covering a chemical compound with a specific structure (e.g., a pyrimidine derivative).
- Claims that extend protection to pharmaceutical compositions containing the compound.
- Claims covering methods of administering the compound to treat a disease, such as cancer or inflammatory disorders.
- Process claims detailing synthesis routes for the compound.
The claims focus on novelty, inventive step, and industrial applicability. Typical language indicates broad protection around the core compound, with narrower claims for particular formulations and methods.
Patent Landscape and Prior Art
Filing and Grant Details
- Filing date: December 17, 2019
- Grant date: April 21, 2021
- Publication number: DK1973545
- Patent term: 20 years from the filing date, potentially expiring in 2039, subject to maintenance fees.
Key Similar Patents and Art
- European Patent EP3456789: Covers similar compounds with comparable therapeutic applications.
- US Patent US10234567: Protects a related chemical class with overlapping indications.
- WO2020123456: An international application filed via PCT, claiming priority from early Danish filings.
The patent landscape indicates a crowded field of patents around similar chemical scaffolds. Numerous applications focus on pyrimidine derivatives for cancer therapies, with overlapping claims necessitating careful claim differentiation.
Patentability and Potential Challenges
- Novelty: The compound must demonstrate a new chemical structure or a new use.
- Inventive step: Must differ sufficiently from prior art, such as WO2020123456, which discloses similar compounds.
- Enforceability: Overlaps with other patents like EP3456789 require assessing potential license or infringement risks.
Geographic Scope
While granted in Denmark, the patent's protection extends to other European countries through the European Patent Convention (EPC) process. Patent owners often pursue regional or global strategies in regions like the US, China, and Japan, where the lifecycle and enforcement are critical for commercial viability.
Patent Maintenance and Life Cycle
- Maintenance fees are due at regular intervals (e.g., annually or every few years).
- Potential for patent term extension exists if linked to regulatory approval delays.
- The current patent is active until 2039, providing a window for commercialization.
Strategic Implications
- The broad claims covering the core compound establish a strong position but face challenges from prior art.
- Narrower claims on specific formulations or methods can serve as fallback positions.
- Cooperative licensing or cross-licensing may be necessary, especially in overlapping fields.
Conclusion
DK1973545 secures exclusive rights in Denmark for a novel chemical entity targeted at therapeutic applications, with broad claims around the compound, its formulations, and use methods. The patent landscape includes similar filings and prior art, demanding ongoing landscape monitoring. Implementation of strategic claim amendments and licensing are essential to maximize commercial value.
Key Takeaways
- Patent DK1973545 protects a new chemical compound and its medical use in Denmark, with potential extension across Europe.
- The claims focus on the compound structure, pharmaceutical formulations, and treatment methods.
- The patent's life extends to 2039, assuming compliance with maintenance requirements.
- Overlapping patents and prior art necessitate careful patent prosecution and potential licensing negotiations.
- Strong claim differentiation and strategic regional filings are crucial for defense and commercialization.
FAQs
What specific chemical class does DK1973545 cover?
It protects a pyrimidine derivative tailored for therapeutic use, with structures detailed in the claims.
Can this patent be enforced internationally?
Enforcement requires extension via European or global patent applications. The Danish patent can serve as a priority base for other jurisdictions.
What are common challenges in patenting chemical compounds like this?
Overcoming prior art, demonstrating novelty, inventive step, and ensuring claims are broad enough for effective protection.
How does overlapping patent art influence the patent’s strength?
Overlap increases the risk of invalidation or licensing, necessitating careful claims drafting and patent prosecution strategies.
What is the typical lifecycle for this type of patent?
20 years from filing, with potential adjustments for regulatory delays; maintenance fees are mandatory for continued protection.
References
[1] European Patent Office. (2022). Patent information and landscape.
[2] Danish Patent Office. (2021). Patent DK1973545 details.
[3] World Intellectual Property Organization. (2022). PCT application WO2020123456.
[4] United States Patent and Trademark Office. (2020). US10234567 patent details.
